Tyrosol derivatives, bearing 3,5-disubstituted isoxazole and 1,4-disubstituted triazole, as potential antileukemia agents by promoting apoptosis

HIGHLIGHTS

• who: Zaineb Abdelkafi-Koubaa and colleagues from the Laboratory of Biomolecules, Venoms and Theranostic Applications, LR IPT01, Pasteur Institute of, University of, have published the paper: Tyrosol Derivatives, Bearing 3,5-Disubstituted Isoxazole and 1,4-Disubstituted Triazole, as Potential Antileukemia Agents by Promoting Apoptosis, in the Journal: Molecules 2022, 27, x FOR PEER REVIEW of /2022/
• what: The authors assess 3 isoxazoles and 1 triazoles for their ability to inhibit the proliferation of K562 cells derived from leukemia as well as primary chronic myeloid leukemia (CML) cells obtained from the peripheral blood of 15 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.